Fibrinolysis in Intermediate-Risk PE Between Prevention and Risk – Unidad de ETV Hospital Gregorio Marañón
Unidad de ETV Hospital Gregorio Marañón shared a post on X about a recent article by Eva Cervilla-Muñoz et al., published in Journal of Clinical Medicine:
“The use of systemic fibrinolysis in intermediate-risk PE remains one of the great clinical debates: Prevent hemodynamic deterioration or assume greater hemorrhagic risk?
In our new article, conducted together with CardioHGUGM, we analyze a real-world cohort.”
Title: Systemic Fibrinolysis in Symptomatic Intermediate-Risk Pulmonary Embolism: A Real-World Cohort Study
Authors: Eva Cervilla-Muñoz, Pablo Demelo-Rodríguez, Rubén Alonso-Beato, Miriam Juárez-Fernández, Iago Sousa-Casasnovas, Lucía Ordieres-Ortega, Marina López-Rubio, Luis-Antonio Alvarez-Sala Walther, Francisco Galeano-Valle
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention